مؤلف: Chesterfield, Missouri, USA) Kumar Singh Satish (Pfizer

Biopharmaceuticals are emerging as frontline medicines to combat several life-threatening and chronic diseases. However, such medicines are expensive to develop and produce on a commercial scale, con …